2018-2025 Angiopoietin 2 Report on Global and United States Market, Status and Forecast, by Players, Types and Applications

Publisher Name :
Date: 16-Apr-2018
No. of pages: 126
Inquire Before Buying

Summary

This report studies the Angiopoietin 2 market status and outlook of global and United States, from angles of players, regions, product types and end industries; this report analyzes the top players in global and United States market, and splits the Angiopoietin 2 market by product type and application/end industries.

The global Angiopoietin 2 market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially the United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Angiopoietin 2.

United States plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of XX.

Geographically, this report is segmented into several key regions, with sales, revenue, market share (%) and growth Rate (%) of Angiopoietin 2 in these regions, from 2013 to 2025 (forecast), covering

- United States

- North America

- Europe

- Asia-Pacific

- South America

- Middle East and Africa

The major players in global and United States market, including

- Amgen Inc.

- AnGes MG, Inc.

- Boehringer Ingelheim GmbH

- Eli Lilly and Company

- F. Hoffmann-La Roche Ltd.

- MedImmune, LLC

- Regeneron Pharmaceuticals, Inc.

- RXi Pharmaceuticals Corporation

- Silence Therapeutics Plc

- Synergys Biotherapeutics, Inc.

On the basis of product, the market is primarily split into

- Atu-111

- BI-836880

- LY-3127804

- MEDI-3617

- Others

On the basis on the end users/application, this report covers

- Hospital

- Clinic

- Others

2018-2025 Angiopoietin 2 Report on Global and United States Market, Status and Forecast, by Players, Types and Applications

Table of Contents
2018-2025 Angiopoietin 2 Report on Global and United States Market, Status and Forecast, by Players, Types and Applications
1 Methodology and Data Source
1.1 Methodology/Research Approach
1.1.1 Research Programs/Design
1.1.2 Market Size Estimation
1.1.3 Market Breakdown and Data Triangulation
1.2 Data Source
1.2.1 Secondary Sources
1.2.2 Primary Sources
1.3 Disclaimer
2 Angiopoietin 2 Market Overview
2.1 Angiopoietin 2 Product Overview
2.2 Angiopoietin 2 Market Segment by Type
2.2.1 Atu-111
2.2.2 BI-836880
2.2.3 LY-3127804
2.2.4 MEDI-3617
2.2.5 Others
2.3 Global Angiopoietin 2 Product Segment by Type
2.3.1 Global Angiopoietin 2 Sales (K Pcs) and Growth (%) by Type (2013, 2017 and 2025)
2.3.2 Global Angiopoietin 2 Sales (K Pcs) and Market Share (%) by Type (2013-2018)
2.3.3 Global Angiopoietin 2 Revenue (Million USD) and Market Share (%) by Type (2013-2018)
2.3.4 Global Angiopoietin 2 Price (USD/Pcs) by Type (2013-2018)
2.4 United States Angiopoietin 2 Product Segment by Type
2.4.1 United States Angiopoietin 2 Sales (K Pcs) and Growth by Type (2013, 2017 and 2025)
2.4.2 United States Angiopoietin 2 Sales (K Pcs) and Market Share by Type (2013-2018)
2.4.3 United States Angiopoietin 2 Revenue (Million USD) and Market Share by Type (2013-2018)
2.4.4 United States Angiopoietin 2 Price (USD/Pcs) by Type (2013-2018)
3 Angiopoietin 2 Application/End Users
3.1 Angiopoietin 2 Segment by Application/End Users
3.1.1 Hospital
3.1.2 Clinic
3.1.3 Others
3.2 Global Angiopoietin 2 Product Segment by Application
3.2.1 Global Angiopoietin 2 Sales (K Pcs) and CGAR (%) by Application (2013, 2017 and 2025)
3.2.2 Global Angiopoietin 2 Sales (K Pcs) and Market Share (%) by Application (2013-2018)
3.3 United States Angiopoietin 2 Product Segment by Application
3.3.1 United States Angiopoietin 2 Sales (K Pcs) and CGAR (%) by Application (2013, 2017 and 2025)
3.3.2 United States Angiopoietin 2 Sales (K Pcs) and Market Share (%) by Application (2013-2018)
4 Angiopoietin 2 Market Status and Outlook by Regions
4.1 Global Market Status and Outlook by Regions
4.1.1 Global Angiopoietin 2 Market Size and CAGR by Regions (2013, 2017 and 2025)
4.1.2 North America
4.1.3 Asia-Pacific
4.1.4 Europe
4.1.5 South America
4.1.6 Middle East and Africa
4.1.7 United States
4.2 Global Angiopoietin 2 Sales and Revenue by Regions
4.2.1 Global Angiopoietin 2 Sales (K Pcs) and Market Share (%) by Regions (2013-2018)
4.2.2 Global Angiopoietin 2 Revenue (Million USD) and Market Share (%) by Regions (2013-2018)
4.2.3 Global Angiopoietin 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
4.2.4 North America Angiopoietin 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
4.2.5 Europe Angiopoietin 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
4.2.6 Asia-Pacific Angiopoietin 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
4.2.7 South America Angiopoietin 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
4.2.8 Middle East and Africa Angiopoietin 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
4.2.9 United States Angiopoietin 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
5 Global Angiopoietin 2 Market Competition by Players/Manufacturers
5.1 Global Angiopoietin 2 Sales (K Pcs) and Market Share by Players (2013-2018)
5.2 Global Angiopoietin 2 Revenue (Million USD) and Share by Players (2013-2018)
5.3 Global Angiopoietin 2 Average Price (USD/Pcs) by Players (2013-2018)
5.4 Global Top Players Angiopoietin 2 Manufacturing Base Distribution, Sales Area, Product Types
5.5 Angiopoietin 2 Market Competitive Situation and Trends
5.5.1 Angiopoietin 2 Market Concentration Rate
5.5.2 Global Angiopoietin 2 Market Share (%) of Top 3 and Top 5 Players
5.5.3 Mergers & Acquisitions, Expansion
6 United States Angiopoietin 2 Market Competition by Players/Manufacturers
6.1 United States Angiopoietin 2 Sales (K Pcs) and Market Share by Players (2013-2018)
6.2 United States Angiopoietin 2 Revenue (Million USD) and Share by Players (2013-2018)
6.3 United States Angiopoietin 2 Average Price (USD/Pcs) by Players (2013-2018)
6.4 United States Angiopoietin 2 Market Share (%) of Top 3 and Top 5 Players
7 Angiopoietin 2 Players/Manufacturers Profiles and Sales Data
7.1 Amgen Inc.
7.1.1 Company Basic Information, Manufacturing Base and Competitors
7.1.2 Angiopoietin 2 Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Amgen Inc. Angiopoietin 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
7.1.4 Main Business/Business Overview
7.2 AnGes MG, Inc.
7.2.1 Company Basic Information, Manufacturing Base and Competitors
7.2.2 Angiopoietin 2 Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 AnGes MG, Inc. Angiopoietin 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
7.2.4 Main Business/Business Overview
7.3 Boehringer Ingelheim GmbH
7.3.1 Company Basic Information, Manufacturing Base and Competitors
7.3.2 Angiopoietin 2 Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Boehringer Ingelheim GmbH Angiopoietin 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
7.3.4 Main Business/Business Overview
7.4 Eli Lilly and Company
7.4.1 Company Basic Information, Manufacturing Base and Competitors
7.4.2 Angiopoietin 2 Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Eli Lilly and Company Angiopoietin 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
7.4.4 Main Business/Business Overview
7.5 F. Hoffmann-La Roche Ltd.
7.5.1 Company Basic Information, Manufacturing Base and Competitors
7.5.2 Angiopoietin 2 Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 F. Hoffmann-La Roche Ltd. Angiopoietin 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
7.5.4 Main Business/Business Overview
7.6 MedImmune, LLC
7.6.1 Company Basic Information, Manufacturing Base and Competitors
7.6.2 Angiopoietin 2 Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 MedImmune, LLC Angiopoietin 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
7.6.4 Main Business/Business Overview
7.7 Regeneron Pharmaceuticals, Inc.
7.7.1 Company Basic Information, Manufacturing Base and Competitors
7.7.2 Angiopoietin 2 Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Regeneron Pharmaceuticals, Inc. Angiopoietin 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
7.7.4 Main Business/Business Overview
7.8 RXi Pharmaceuticals Corporation
7.8.1 Company Basic Information, Manufacturing Base and Competitors
7.8.2 Angiopoietin 2 Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 RXi Pharmaceuticals Corporation Angiopoietin 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
7.8.4 Main Business/Business Overview
7.9 Silence Therapeutics Plc
7.9.1 Company Basic Information, Manufacturing Base and Competitors
7.9.2 Angiopoietin 2 Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 Silence Therapeutics Plc Angiopoietin 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
7.9.4 Main Business/Business Overview
7.10 Synergys Biotherapeutics, Inc.
7.10.1 Company Basic Information, Manufacturing Base and Competitors
7.10.2 Angiopoietin 2 Product Category, Application and Specification
7.10.2.1 Product A
7.10.2.2 Product B
7.10.3 Synergys Biotherapeutics, Inc. Angiopoietin 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
7.10.4 Main Business/Business Overview
8 Angiopoietin 2 Manufacturing Cost, Industrial Chain and Downstream Buyers
8.1 Angiopoietin 2 Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Angiopoietin 2 Industrial Chain Analysis
8.4 Downstream Buyers in United States
9 Marketing Strategy Analysis, Distributors and Market Effect Factors
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Distributors in Untied States
9.3 Market Effect Factors Analysis
9.3.1 Economic/Political Environmental Change
9.3.2 Downstream Demand Change
9.3.3 Technology Progress in Related Industry
9.3.4 Substitutes Threat
10 Global Angiopoietin 2 Market Forecast
10.1 Global Angiopoietin 2 Sales, Revenue Forecast (2018-2025)
10.1.1 Global Angiopoietin 2 Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
10.1.2 Global Angiopoietin 2 Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
10.2 United States Angiopoietin 2 Market Forecast
10.2.1 United States Angiopoietin 2 Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
10.2.2 United States Angiopoietin 2 Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
10.3 Global Angiopoietin 2 Forecast by Regions
10.3.1 North America Angiopoietin 2 Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
10.3.2 Europe Angiopoietin 2 Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
10.3.3 Asia-Pacific Angiopoietin 2 Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
10.3.4 South America Angiopoietin 2 Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
10.3.5 Middle East and Africa Angiopoietin 2 Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
10.4 Angiopoietin 2 Forecast by Type
10.4.1 Global Angiopoietin 2 Sales (K Pcs) and Revenue (Million USD) Forecast by Type (2018-2025)
10.4.2 United States Angiopoietin 2 Sales (K Pcs) and Revenue (Million USD) Forecast by Type (2018-2025)
10.5 Angiopoietin 2 Forecast by Application
10.5.1 Global Angiopoietin 2 Sales (K Pcs) Forecast by Application (2018-2025)
10.5.2 United States Angiopoietin 2 Sales (K Pcs) Forecast by Application (2018-2025)
11 Research Findings and Conclusion
List of Tables and Figures
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Figure Angiopoietin 2 Product Picture
Figure Global Angiopoietin 2 Revenue (Million USD) Status and Outlook (2013-2025)
Figure United States Angiopoietin 2 Revenue (Million USD) Status and Outlook (2013-2025)
Figure Product Picture of Atu-111
Table Major Players of Atu-111
Figure Global Atu-111 Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Product Picture of BI-836880
Table Major Players of BI-836880
Figure Global BI-836880 Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Product Picture of LY-3127804
Table Major Players of LY-3127804
Figure Global LY-3127804 Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Product Picture of MEDI-3617
Table Major Players of MEDI-3617
Figure Global MEDI-3617 Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Product Picture of Others
Table Major Players of Others
Figure Global Others Sales (K Pcs) and Growth Rate (%)(2013-2018)
Table Global Angiopoietin 2 Sales (K Pcs) and Growth Rate (%) Comparison by Type (2013, 2017 and 2025)
Table Global Angiopoietin 2 Sales (K Pcs) by Type (2013-2018)
Table Global Angiopoietin 2 Sales Share (%) by Type (2013-2018)
Figure Global Angiopoietin 2 Sales Market Share (%) by Type (2013-2018)
Figure Global Angiopoietin 2 Sales Market Share (%) by Type in 2017
Table Global Angiopoietin 2 Revenue (Million USD) by Type (2013-2018)
Table Global Angiopoietin 2 Revenue Share (%) by Type (2013-2018)
Figure Global Angiopoietin 2 Revenue Share (%) by Type (2013-2018)
Figure 2017 Global Angiopoietin 2 Revenue Market Share (%) by Type
Table Global Angiopoietin 2 Price (USD/Pcs) by Type (2013-2018)
Table United States Angiopoietin 2 Sales (K Pcs) and Growth Rate (%) Comparison by Type (2013, 2017 and 2025)
Table United States Angiopoietin 2 Sales (K Pcs) by Type (2013-2018)
Table United States Angiopoietin 2 Sales Share (%) by Type (2013-2018)
Figure United States Angiopoietin 2 Sales Market Share (%) by Type (2013-2018)
Figure United States Angiopoietin 2 Sales Market Share (%) by Type in 2017
Table United States Angiopoietin 2 Revenue (Million USD) by Type (2013-2018)
Table United States Angiopoietin 2 Revenue Share (%) by Type (2013-2018)
Figure United States Angiopoietin 2 Revenue Share (%)by Type (2013-2018)
Figure 2017 United States Angiopoietin 2 Revenue Market Share (%) by Type
Table United States Angiopoietin 2 Price (USD/Pcs) by Type (2013-2018)
Figure Hospital Examples
Figure Clinic Examples
Figure Others Examples
Table Global Angiopoietin 2 Sales (K Pcs) Comparison by Application (2013-2025)
Table Global Angiopoietin 2 Sales (K Pcs) by Application (2013-2018)
Table Global Angiopoietin 2 Sales Share (%) by Application (2013-2018)
Figure Global Angiopoietin 2 Sales Market Share (%) by Application (2013-2018)
Figure Global Angiopoietin 2 Sales Market Share (%) by Application in 2017
Table United States Angiopoietin 2 Sales (K Pcs) Comparison by Application (2013-2025)
Table United States Angiopoietin 2 Sales (K Pcs) by Application (2013-2018)
Table United States Angiopoietin 2 Sales Share (%) by Application (2013-2018)
Figure United States Angiopoietin 2 Sales Market Share (%) by Application (2013-2018)
Figure United States Angiopoietin 2 Sales Market Share (%) by Application in 2017
Table Global Angiopoietin 2 Revenue (Million USD) and CAGR Comparison by Regions (2013-2025)
Figure North America Angiopoietin 2 Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure Asia-Pacific Angiopoietin 2 Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure Europe Angiopoietin 2 Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure South America Angiopoietin 2 Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure Middle East and Africa Angiopoietin 2 Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure United States Angiopoietin 2 Revenue (Million USD) and Growth Rate (%)(2013-2025)
Table Global Angiopoietin 2 Sales (K Pcs) by Regions (2013-2018)
Table Global Angiopoietin 2 Sales Market Share (%) by Regions (2013-2018)
Figure Global Angiopoietin 2 Sales Market Share (%) by Regions (2013-2018)
Figure 2017 Global Angiopoietin 2 Sales Market Share (%) by Regions
Figure 2017 United States Angiopoietin 2 Sales Market Share (%) in Global Market
Table Global Angiopoietin 2 Revenue (Million USD) by Regions (2013-2018)
Table Global Angiopoietin 2 Revenue Market Share (%) by Regions (2013-2018)
Figure Global Angiopoietin 2 Revenue Market Share (%) by Regions (2013-2018)
Figure 2017 Global Angiopoietin 2 Revenue Market Share (%) by Regions
Figure 2017 United States Angiopoietin 2 Revenue Market Share (%) in Global Market
Table Global Angiopoietin 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table North America Angiopoietin 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table Europe Angiopoietin 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table Asia-Pacific Angiopoietin 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table South America Angiopoietin 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table Middle East and Africa Angiopoietin 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table United States Angiopoietin 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table Global Angiopoietin 2 Sales (K Pcs) of Key Players (2013-2018)
Table Global Angiopoietin 2 Sales Share (%) by Players (2013-2018)
Figure 2017 Global Angiopoietin 2 Sales Share (%) by Players
Figure 2018 Global Angiopoietin 2 Sales Share (%) by Players
Table Global Angiopoietin 2 Revenue (Million USD) by Players (2013-2018)
Table Global Angiopoietin 2 Revenue Share (%) by Players (2013-2018)
Table 2017 Global Angiopoietin 2 Revenue Share (%) by Players
Table 2018 Global Angiopoietin 2 Revenue Share (%) by Players
Table Global Market Angiopoietin 2 Average Price (USD/Pcs) by Players (2013-2018)
Table Global Angiopoietin 2 Top Players Manufacturing Base Distribution and Sales Area
Table Global Angiopoietin 2 Top Players Product Category
Figure Global Angiopoietin 2 Market Share (%) of Top 3 Players
Figure Global Angiopoietin 2 Market Share (%) of Top 5 Players
Table United States Angiopoietin 2 Sales (K Pcs) by Players (2013-2018)
Table United States Angiopoietin 2 Sales Market Share (%) by Players (2013-2018)
Figure 2017 United States Angiopoietin 2 Sales Share (%) by Players
Figure 2018 United States Angiopoietin 2 Sales Share (%) by Players
Table United States Angiopoietin 2 Revenue (Million USD) by Players (2013-2018)
Table United States Angiopoietin 2 Revenue Market Share (%) by Players (2013-2018)
Table 2017 United States Angiopoietin 2 Revenue Share (%) by Players
Table 2018 United States Angiopoietin 2 Revenue Share (%) by Players
Table United States Market Angiopoietin 2 Average Price (USD/Pcs) by Players (2013-2018)
Figure United States Angiopoietin 2 Market Share (%) of Top 3 Players
Figure United States Angiopoietin 2 Market Share (%) of Top 5 Players
Table Amgen Inc. Basic Information List
Table Amgen Inc. Angiopoietin 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Amgen Inc. Angiopoietin 2 Sales Growth Rate (2013-2018)
Figure Amgen Inc. Angiopoietin 2 Sales Global Market Share (%)(2013-2018)
Figure Amgen Inc. Angiopoietin 2 Revenue Global Market Share (%)(2013-2018)
Table AnGes MG, Inc. Basic Information List
Table AnGes MG, Inc. Angiopoietin 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure AnGes MG, Inc. Angiopoietin 2 Sales Growth Rate (2013-2018)
Figure AnGes MG, Inc. Angiopoietin 2 Sales Global Market Share (%)(2013-2018)
Figure AnGes MG, Inc. Angiopoietin 2 Revenue Global Market Share (%)(2013-2018)
Table Boehringer Ingelheim GmbH Basic Information List
Table Boehringer Ingelheim GmbH Angiopoietin 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Boehringer Ingelheim GmbH Angiopoietin 2 Sales Growth Rate (2013-2018)
Figure Boehringer Ingelheim GmbH Angiopoietin 2 Sales Global Market Share (%)(2013-2018)
Figure Boehringer Ingelheim GmbH Angiopoietin 2 Revenue Global Market Share (%)(2013-2018)
Table Eli Lilly and Company Basic Information List
Table Eli Lilly and Company Angiopoietin 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Eli Lilly and Company Angiopoietin 2 Sales Growth Rate (2013-2018)
Figure Eli Lilly and Company Angiopoietin 2 Sales Global Market Share (%)(2013-2018)
Figure Eli Lilly and Company Angiopoietin 2 Revenue Global Market Share (%)(2013-2018)
Table F. Hoffmann-La Roche Ltd. Basic Information List
Table F. Hoffmann-La Roche Ltd. Angiopoietin 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure F. Hoffmann-La Roche Ltd. Angiopoietin 2 Sales Growth Rate (2013-2018)
Figure F. Hoffmann-La Roche Ltd. Angiopoietin 2 Sales Global Market Share (%)(2013-2018)
Figure F. Hoffmann-La Roche Ltd. Angiopoietin 2 Revenue Global Market Share (%)(2013-2018)
Table MedImmune, LLC Basic Information List
Table MedImmune, LLC Angiopoietin 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure MedImmune, LLC Angiopoietin 2 Sales Growth Rate (2013-2018)
Figure MedImmune, LLC Angiopoietin 2 Sales Global Market Share (%)(2013-2018)
Figure MedImmune, LLC Angiopoietin 2 Revenue Global Market Share (%)(2013-2018)
Table Regeneron Pharmaceuticals, Inc. Basic Information List
Table Regeneron Pharmaceuticals, Inc. Angiopoietin 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Regeneron Pharmaceuticals, Inc. Angiopoietin 2 Sales Growth Rate (2013-2018)
Figure Regeneron Pharmaceuticals, Inc. Angiopoietin 2 Sales Global Market Share (%)(2013-2018)
Figure Regeneron Pharmaceuticals, Inc. Angiopoietin 2 Revenue Global Market Share (%)(2013-2018)
Table RXi Pharmaceuticals Corporation Basic Information List
Table RXi Pharmaceuticals Corporation Angiopoietin 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure RXi Pharmaceuticals Corporation Angiopoietin 2 Sales Growth Rate (2013-2018)
Figure RXi Pharmaceuticals Corporation Angiopoietin 2 Sales Global Market Share (%)(2013-2018)
Figure RXi Pharmaceuticals Corporation Angiopoietin 2 Revenue Global Market Share (%)(2013-2018)
Table Silence Therapeutics Plc Basic Information List
Table Silence Therapeutics Plc Angiopoietin 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Silence Therapeutics Plc Angiopoietin 2 Sales Growth Rate (2013-2018)
Figure Silence Therapeutics Plc Angiopoietin 2 Sales Global Market Share (%)(2013-2018)
Figure Silence Therapeutics Plc Angiopoietin 2 Revenue Global Market Share (%)(2013-2018)
Table Synergys Biotherapeutics, Inc. Basic Information List
Table Synergys Biotherapeutics, Inc. Angiopoietin 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Synergys Biotherapeutics, Inc. Angiopoietin 2 Sales Growth Rate (2013-2018)
Figure Synergys Biotherapeutics, Inc. Angiopoietin 2 Sales Global Market Share (%)(2013-2018)
Figure Synergys Biotherapeutics, Inc. Angiopoietin 2 Revenue Global Market Share (%)(2013-2018)
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Angiopoietin 2
Figure Angiopoietin 2 Industrial Chain Analysis
Table Major Buyers of Angiopoietin 2
Table Distributors/Traders List
Figure Global Angiopoietin 2 Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure Global Angiopoietin 2 Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
Figure United States Angiopoietin 2Angiopoietin 2 Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure United States Angiopoietin 2 Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
Table Global Angiopoietin 2 Sales (K Pcs) Forecast by Regions (2018-2025)
Figure Global Angiopoietin 2 Sales Market Share (%) Forecast by Regions (2018-2025)
Figure North America Angiopoietin 2 Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure North America Angiopoietin 2 Revenue and Growth Rate (%) Forecast (2018-2025)
Figure Europe Angiopoietin 2 Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure Europe Angiopoietin 2 Revenue and Growth Rate (%) Forecast (2018-2025)
Figure Asia-Pacific Angiopoietin 2 Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure Asia-Pacific Angiopoietin 2 Revenue and Growth Rate (%) Forecast (2018-2025)
Figure South America Angiopoietin 2 Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure South America Angiopoietin 2 Revenue and Growth Rate (%) Forecast (2018-2025)
Figure Middle East and Africa Angiopoietin 2 Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure Middle East and Africa Angiopoietin 2 Revenue and Growth Rate (%) Forecast (2018-2025)
Table Global Angiopoietin 2 Sales (Million USD) Forecast by Type (2018-2025)
Figure Global Angiopoietin 2 Sales Market Share (%) Forecast by Type (2018-2025)
Table Global Angiopoietin 2 Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Angiopoietin 2 Revenue Market Share (%) Forecast by Type (2018-2025)
Table United States Angiopoietin 2 Sales (Million USD) Forecast by Type (2018-2025)
Figure United States Angiopoietin 2 Sales Market Share (%) Forecast by Type (2018-2025)
Table United States Angiopoietin 2 Revenue (Million USD) Forecast by Type (2018-2025)
Figure United States Angiopoietin 2 Revenue Market Share (%) Forecast by Type (2018-2025)
Table Global Angiopoietin 2 Sales (K Pcs) Forecast by Application (2018-2025)
Figure Global Angiopoietin 2 Sales Forecast by Application (2018-2025)
Table United States Angiopoietin 2 Sales (K Pcs) Forecast by Application (2018-2025)
Figure United States Angiopoietin 2 Sales Forecast by Application (2018-2025)
  • Global Myelodysplastic Syndrome Market Insights, Forecast to 2025
    Published: 18-Jan-2019        Price: US 3900 Onwards        Pages: 128
    Myelodysplastic syndromes (MDS) are a group of cancers in which immature blood cells in the bone marrow do not mature and therefore do not become healthy blood cells.[2] Early on there are typically no symptoms.Later symptoms may include feeling tired, shortness of breath, easy bleeding, or frequent infections.[2] Some types may develop into acute myeloid leukemia. The presence of diagnostic tools is the key driver for the growth of this market. Diagnosis techniques like blood count, peri......
  • Global Myasthenia Gravis Drugs Market Insights, Forecast to 2025
    Published: 18-Jan-2019        Price: US 3900 Onwards        Pages: 120
    Acetylcholine esterase (AChE) inhibitors are considered to be the basic treatment of myasthenia gravis (MG). Edrophonium is primarily used as a diagnostic tool owing to its short half-life. Pyridostigmine is used for long-term maintenance. The market is witnessing the rapid development of novel drugs such as monoclonal antibodies, which is one of the primary factors driving this market's growth prospects. Most drug manufacturers are increasingly focussing on the development of monoclonal ......
  • Global MRSA Drugs Market Insights, Forecast to 2025
    Published: 18-Jan-2019        Price: US 3900 Onwards        Pages: 122
    Staphylococcus aureus is a bacteria commonly found on nose or skin of healthy people. MRSA i.e., methicillin-resistant staphylococcus aureus, is thus a type of staphylococcus aureus that is resistant to beta-lactam antibiotic called methicillin. MRSA strains do not respond to methicillin treatment. Around 1% of the population carrying staphylococcus aureus on their nose or skin are infected by MRSA. The infection causes skin and tissue infection, and is transmitted by direct skin-to-skin contact......
  • Global Fibrin Sealants Market Insights, Forecast to 2025
    Published: 18-Jan-2019        Price: US 3900 Onwards        Pages: 125
    Fibrin sealant, a two-component substance consisting of thrombin and fibrinogen, is used as a hemostatic or adhesive in various surgical solutions. In clinical practice, a fibrin sealant consists of a concentrated solution of fibrinogen and Factor XIII, which combine with a solution of calcium and thrombin to form a coagulum that stimulates clotting. Beriplast P and TISSEEL are some of the commercially available fibrin sealants. The Americas accounted for 48% of the market share during th......
  • Global Female Contraceptive Market Insights, Forecast to 2025
    Published: 18-Jan-2019        Price: US 3900 Onwards        Pages: 110
    Female contraceptives, also known as female birth control are methods of preventing pregnancy that primarily involve the female physiology. Female contraceptive devices account for major shares of the contraceptive pills market throughout the forecast period. The increasing adoption of female contraceptive devices will drive the growth of this product segment in the female contraceptive market. The Americas will be the major revenue contributor to the contraceptive pills market thr......
  • Global Female Condoms Market Insights, Forecast to 2025
    Published: 18-Jan-2019        Price: US 3900 Onwards        Pages: 114
    A female condom is a birth control device that acts as a barrier to prevent sexual fluids from entering the vagina during intercourse. It protects against pregnancy and sexually transmitted infections (STIs). The online stores will be the fastest-growing segment and will continue to maintain its lead in the global market. Much of the segment's growth is due to its higher penetration rate and adoptability. Female condoms are easily accessible online and allow for useful comparison in terms......
  • Global Excipients Market Insights, Forecast to 2025
    Published: 18-Jan-2019        Price: US 3900 Onwards        Pages: 111
    Excipients are inert substances that are generally used to manufacture different forms of drugs and are present in the finished products. Excipients help in providing long-term stability and make solid formulations bulkier. They also improve the functionality of drugs and make them safer. Based on functionality, the pharmaceutical excipients market is segmented into fillers & diluents, binders, suspending & viscosity agents, flavoring agents & sweeteners, coating agents, colorants, disint......
  • Global Consumer Healthcare Market Insights, Forecast to 2025
    Published: 18-Jan-2019        Price: US 3900 Onwards        Pages: 127
    Consumer healthcare products include trusted brands of multivitamins and iron supplements, in addition to products for allergies, personal hygiene, sleep support, alertness and cold and flu. Consumer health products do not require a written prescription from healthcare professionals but can be purchased directly from a pharmacy store. The global Consumer Healthcare market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx%......
  • Global Intravenous (IV) Ibuprofen Market Insights, Forecast to 2025
    Published: 18-Jan-2019        Price: US 3900 Onwards        Pages: 114
    Intravenous (IV) ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) used to reduce or treat pain, fever, and inflammation occurred due to a disease, operative procedures or trauma, and acute illness. The global Intravenous (IV) Ibuprofen market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Intravenous (IV) Ibuprofen ma......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs